#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Synovial sarcoma X-linked lymphoproliferative syndrome Gastrointestinal stromal tumour Lymphangiosarcoma Focal segmental glomerulosclerosis Kearns-Sayre syndrome Congenital hypotransferrinaemia Glomerulonephritis chronic Hereditary motor and sensory neuropathy Krabbe's disease Thrombotic microangiopathy Infantile spasms Polycythaemia vera Chronic graft versus host disease Warm autoimmune haemolytic anaemia More trials…

    Learn about Rare Diseases

    Pemphigus – Treatment Mucopolysaccharidosis II Marginal zone lymphoma refractory Breast angiosarcoma metastatic – Life with Disease Kearns-Sayre syndrome – Treatment Leiomyosarcoma – Diagnostics Urea cycle disorder Lennox-Gastaut syndrome – Diagnostics Sarcoidosis – Life with Disease Anaplastic thyroid cancer – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Maralixibat Chloride Cobicistat Vgl101 Mitazalimab Eye103 Mosaic Hbcoreag Diazepam Nefopam [14C] DC-806 Olopatadine Deferoxamine Mesilate Samuraciclib Rezvilutamide Dextran 70 Ataluren Teropavimab Amivantamab RUBIDIUM CHLORIDE ATIRMOCICLIB Kpl-404 More therapies…

    Learn about Your Condition

    Hypotonia Habitual abortion Ependymoma malignant Infertility male Dementia Dupuytren's contracture Systemic scleroderma Giant cell arteritis Tubulointerstitial nephritis Muscle hypertrophy Proteinuria Lymphatic malformation Embolism venous Tympanic membrane perforation Brain neoplasm malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on Roxadustat for Treating Anemia in Children with Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Nephrogenic anaemia
    Investigated Drugs:
    • Methoxy Polyethylene Glycol-Epoetin Beta
    • Roxadustat
    • Epoetin Alfa
    Belgium Bulgaria Croatia Czechia Denmark Finland +14

  • Study on Venetoclax and Obinutuzumab for Adults with Recurring Chronic Lymphocytic Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia recurrent
    Investigated Drugs:
    • Obinutuzumab
    • Venetoclax
    Austria Bulgaria Germany Italy Romania Spain

  • Study on Elranatamab for Patients with Multiple Myeloma Continuing from Previous Clinical Trials

    Recruiting

    3 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Elranatamab
    France Germany Spain

  • Long-Term Safety Study of MB-CART19.1, MB-CART20.1, and Zamtocabtagene Autoleucel for Patients with Advanced Melanoma or B-Cell Malignancies

    Recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia recurrent
    • Chronic lymphocytic leukaemia recurrent
    • Chronic lymphocytic leukaemia refractory
    Investigated Drugs:
    • Mb-Cart20.1
    • Autologous T-Cells Transduced With Lentiviral Vector Expressing A Chimeric Antigen Receptor Directed Against Cd19
    • Zamtocabtagene Autoleucel
    Germany

  • Study on the Effectiveness and Safety of Tislelizumab for Patients with Newly Diagnosed Hodgkin Lymphoma Who Cannot Have Standard Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Tislelizumab
    Italy

  • Study on Luspatercept for Improving Brain Oxygenation in Patients with Non-Transfusion Dependent Thalassemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Thalassaemia beta
    • Thalassaemia
    Investigated Drugs:
    • Luspatercept
    The Netherlands
Previous Page
1 … 28 29 30 31 32 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!